COLLPLANT BIOTECH. IS-01 (CPT) — Financial Flexibility Index

Latest as of December 2025: -0.62x

COLLPLANT BIOTECH. IS-01 (CPT) has a Financial Flexibility Index of -0.62x as of December 2025. Free cash flow of €-2.92 Million (operating CF €-2.94 Million minus capex €15.00K) represents -1% of total liabilities (€4.70 Million). Also explore COLLPLANT BIOTECH. IS-01 annual equity growth to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.62x
Free Cash Flow / Total Liabilities

Free Cash Flow

€-2.92 Million
Operating CF − Capex

Total Liabilities

€4.70 Million
EUR

Capital Expenditures

€15.00K
EUR

COLLPLANT BIOTECH. IS-01 Financial Flexibility Index (2021–2025)

Historical Financial Flexibility Index trend for COLLPLANT BIOTECH. IS-01 across 5 annual periods. Check COLLPLANT BIOTECH. IS-01 liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Annual Financial Flexibility Index for COLLPLANT BIOTECH. IS-01 (2021–2025)

Year-by-year free cash flow to debt coverage for COLLPLANT BIOTECH. IS-01. For the full company profile including market capitalisation, see COLLPLANT BIOTECH. IS-01 market cap and net worth.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2025 -2.00x €-9.39 Million €-9.42 Million €4.70 Million ▲ +23.1%
2024 -2.59x €-13.61 Million €-14.09 Million €5.25 Million ▼ -730.0%
2023 -0.31x €-1.81 Million €-2.76 Million €5.79 Million ▲ +86.1%
2022 -2.26x €-12.38 Million €-13.70 Million €5.49 Million ▼ -436.7%
2021 0.67x €4.09 Million €2.50 Million €6.10 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities